Document:

Employment Agreement

 Exhibit 10.28 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of
September 6, 2007, by Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Employer”), and Nancy J. Wysenski (the “Employee”). 
 WHEREAS, the Employee and the Board of Directors of the Employer have each determined that entering into this Agreement is advisable and desirable; and 
 WHEREAS, the Board of Directors of the Employer has approved this Agreement upon the terms set forth herein; 
 NOW THEREFORE, in consideration of the mutual premises and agreements contained herein, the parties hereto, intending to be legally bound, agree as
follows: 
 ARTICLE 1. DEFINITIONS.  
 For the purposes of this Agreement, the following terms have the meanings specified or referred to in this Article 1. 
 “Agreement” means this Employment Agreement, including the Exhibits hereto, as amended from time to time. 
 “Basic Compensation” means Salary and Benefits. 
 “Benefits” shall have the meaning set forth in
Section 3.1(b). 
 “Board of Directors” means the board of directors of the Employer. 
 “Confidential Information” means any and all: 
 (a) trade secrets concerning the business and affairs of the Employer, product specifications, data, know-how, formulae, compositions, processes, designs, sketches, photographs, graphs, drawings, samples, inventions
and ideas, past, current, and planned research and development, current and planned manufacturing or distribution methods and processes, customer lists, current and anticipated customer requirements, price lists, market studies, business plans,
computer software and programs (including object code and source code), computer software and database technologies, systems, structures, and architectures (and related formulae, compositions, processes, improvements, devices, know-how, inventions,
discoveries, concepts, ideas, designs, methods and information); 
  

 -1- 

 (b) information concerning the business and affairs of the Employer (which includes unpublished financial
statements, financial projections and budgets, unpublished and projected sales, capital spending budgets and plans, the names and backgrounds of key personnel, to the extent not publicly known, personnel training and techniques and materials)
however documented; and 
 (c) notes, analysis, compilations, studies, summaries, and other material prepared by or for the Employer
containing or based, in whole or in part, on any information included in the foregoing. 
 “disability” shall have the
meaning set forth in Section 6.2. 
 “Effective Date” means September 6, 2007. 
 “Employment Period” shall have the meaning set forth in Section 2.2. 
 “Fiscal Year” means the Employer’s fiscal year, as it exists on the Effective Date or as changed from time to time. 
 “for cause” shall have the meaning set forth in Section 6.3. 
 “for good reason” shall have the meaning set forth in Section 6.4. 
 “Incentive Compensation” shall have the meaning set forth in Section 3.2. 
 “person” means any individual, corporation (including any non-profit corporation), general or limited partnership, limited liability
company, joint venture, estate, trust, association, organization, or governmental body. 
 “Post-Employment Period” shall
have the meaning set forth in Article 8. 
 “Renewal Term” shall have the meaning set forth in Section 2.2. 

“Salary” shall have the meaning set forth in Section 3.1(a). 
  

 -2- 

 ARTICLE 2. EMPLOYMENT TERMS AND DUTIES. 
 Section 2.1 Employment. The Employer hereby employs the Employee, and the Employee hereby accepts employment by the Employer, upon the
terms and conditions set forth in this Agreement. 
 Section 2.2 Term. Subject to the provisions of Article 6, the term of
the Employee’s employment under this Agreement will be a rolling twenty-four month period commencing each day after the Effective Date and ending on the twenty-four month anniversary of such day (the “Employment Period”). For purposes
of this Agreement, employment and compensation paid by any direct or indirect subsidiary of the Employer will be deemed to be employment and compensation paid by the Employer. 
 Section 2.3 Duties. The Employee will have such duties as are assigned or delegated to the Employee by the Chief Executive Officer,
and will serve as Chief Operating Officer of the Employer. The Employee will devote the Employee’s business, time, attention, skill, and energy to the business of the Employer, will promote the success of the Employer’s business, and will
cooperate with the Chief Executive Officer and the Board of Directors in the advancement of the best interests of the Employer. Nothing in this Section 2.3, however, will prevent the Employee from engaging in additional activities in connection
with personal investments, corporate directorships and community affairs that are not inconsistent with the Employee’s duties under this Agreement. It is expressly understood and agreed that to the extent any such activities have been conducted
by the Employee prior to the Effective Date, the continued conduct of such activities (or the conduct of activities similar in nature and scope thereto) subsequent to the Effective Date shall not thereafter be deemed to be inconsistent with the
Employee’s duties under this Agreement. The Employee shall, from time to time, inform the Chief Executive Officer of those additional activities in which the Employee is engaged. If, at any time, the Employee is elected as a director of the
Employer or as a director or officer of any of Employer’s subsidiaries, the Employee will fulfill the Employee’s duties as such director or officer without additional compensation. 
 Section 2.4 Director’s and Officer’s Liability Coverage. The Employer shall cause the Employee to be (a) indemnified as
an officer and/or director of the Employer or any of its affiliates, to the extent applicable, to the maximum extent permitted by applicable law, and (b) covered by director’s and officer’s liability insurance in connection with the
Employee serving as an officer and/or director of Employer or any of its affiliates. The provisions of this Section 2.4 shall survive termination of this Agreement for any reason. 
 ARTICLE 3. COMPENSATION. 
 Section 3.1 Basic Compensation. 
 (a) Salary. The Employee will be paid an annual salary of $450,000, subject to adjustment as provided below (the “Salary”), which
will be payable in equal periodic installments according to the Employer’s customary payroll practices, but no less frequently than 

  

 -3- 

 
the 15th and the last day of each month. The Salary, upon a
recommendation by the Chief Executive Officer, will be reviewed by the Compensation Committee of the Board of Directors (the “Committee”) not less frequently than annually, and be adjusted in the sole discretion of the Committee, but in no
event will the Salary be less than $450,000 per year. In determining the amount of any adjustment to Salary, the Committee shall take into account inflation, merit, changes in responsibilities and industry salary practices for executives. Any
increase in Salary shall not serve to limit or reduce any other obligation to the Employee under this Agreement. 
 (b)
Benefits. The Employee will, during the Employment Period, be permitted to participate in such incentive, savings, pension, profit sharing, bonus, life insurance, hospitalization and major medical, and other employee benefit plans,
practices, policies and programs, of the Employer that may be in effect from time to time, to the extent the Employee is eligible under the terms of those plans (collectively, the “Benefits”). 
 (c) Stock Options/Restricted Shares. To the extent the Employer determines to award stock options, restricted shares or other similar
consideration to management personnel based upon duration of employment or achieving performance targets, or both, the Employee shall be permitted to participate in such programs. For each Fiscal Year or part thereof during the Employment Period the
Employee shall be eligible to earn as additional compensation for the services to be rendered by the Employee pursuant to this Agreement, long-term equity incentives in an amount equal up to two hundred percent (200%) of the Salary for such
Fiscal Year (or such lesser (including zero) or greater percent of the Salary for such Fiscal Year as is recommended in good faith to the Committee by the Chief Executive Officer of the Employer and approved by the Committee). On September 6,
2007 (the Employee’s first day of employment with the Employer), the Employee will be (i) granted 100,000 stock options under the 2004 Stock Incentive Plan and/or the 2007 Stock Incentive Plan, with all such options valued with reference
to the closing market price on the September 6, 2007 and (ii) in lieu of a 2007 option grant, paid an additional cash bonus of $100,000. 
 Section 3.2 Incentive Compensation. For each Fiscal Year or part thereof during the Employment Period the Employee shall be eligible to be paid in cash additional compensation (the “Incentive Compensation”) for
the services to be rendered by the Employee pursuant to this Agreement, an amount equal to fifty-five percent (55%) of the Salary for such Fiscal Year (or such lesser (including zero) or greater (not to exceed two hundred) percent of the Salary
for such Fiscal Year as is recommended in good faith to the Committee by the Chief Executive Officer of the Employer and approved by the Committee) if the Employer achieves certain performance targets set by the Committee (the “Performance
Targets”) for such Fiscal Year. Incentive Compensation for each Fiscal Year or part thereof shall be paid as soon as practicable following the receipt by the Employer of its audited financial statements for the Fiscal Year for which the
Incentive Compensation is being paid, unless the Employee shall elect to defer the receipt of such Incentive Compensation. The Employee shall be permitted to submit a proposal for additional incentive compensation with respect to the period
commencing on the date hereof and ending at the end of the Employers’ current Fiscal Year, and the Employer shall consider such proposal in good faith. 
  

 -4- 

 Section 3.3 Relocation. The Employer will provide the Employee with a relocation
allowance of up to $75,000 to cover documented and reasonable moving expenses that are incurred within twelve (12) months of the Effective Date, in connection with her relocation to the Chadds Ford, PA area. The Employee shall also be eligible
for temporary living expense reimbursement, to be pre-approved by Employer, for up to twelve (12) months after the Effective Date. All such sums must be repaid to the Employer in the event the Employee voluntarily terminates his employment
within eighteen (18) months of the Effective Date. Additionally, should her employment status materially change involuntarily during her first twelve months of employment, she will be eligible for a one-time reverse relocation bonus of $75,000.

 ARTICLE 4. FACILITIES AND EXPENSES. 
 Section 4.1 Reimbursement. The Employer will furnish the Employee office space, equipment, supplies, and such other facilities and personnel as the Employer deems necessary or appropriate for the performance of the
Employee’s duties under this Agreement. The Employer will pay the Employee’s dues in such professional societies and organizations as are appropriate, and will pay on behalf of the Employee (or reimburse the Employee for) reasonable
expenses incurred by the Employee at the request of, or on behalf of, the Employer in the performance of the Employee’s duties pursuant to this Agreement, and in accordance with the Employer’s employment policies, including reasonable
expenses incurred by the Employee in attending conventions, seminars, and other business meetings and in appropriate business entertainment activities. The Employee must file expense reports with respect to such expenses in accordance with the
Employer’s policies. 
 Section 4.2 Motor Vehicle Allowance. As of the Effective Date, the Employee will be entitled
to use of an automobile, and a replacement thereof, mutually acceptable to the Employee and the Employer, at least every three (3) fiscal years after the Effective Date during the Employment Term. The Employer will reimburse the Employee for
all operating expenses relating thereto upon the Employee’s submission of appropriate documentation as set forth in Section 4.1. The Employer will determine the actual value, if any, of the Employee’s non-business use of such
automobile and will furnish the Employee with a W-2 Wage and Tax Statement, grossed up for taxes, to be included in the Employee’s income tax returns, in accordance with prevailing Internal Revenue Service regulations. 
 ARTICLE 5. VACATIONS AND HOLIDAYS. 
 The
Employee will be entitled to paid vacation each Fiscal Year in accordance with the vacation policies of the Employer in effect for its executive officers from time to time, provided that in no event shall such number of paid vacation days be fewer
than twenty. Vacation must be taken by the Employee at such time or times as approved by the Chief Executive Officer. The Employee will also be entitled to the paid holidays and other paid leave set forth in the Employer’s policies. Vacation
days and holidays during any Fiscal Year that are not used by the Employee during such Fiscal Year may be used in any subsequent Fiscal Year. 
  

 -5- 

 ARTICLE 6. TERMINATION AND ELECTION NOT TO RENEW. 
 Section 6.1 Events of Termination. The Employment Period, the Employee’s Basic Compensation and Incentive Compensation, and any
and all other rights of the Employee under this Agreement or otherwise as an employee of the Employer will terminate (except as otherwise provided in this Article 6): 
 (a) upon the death of the Employee; 
 (b) upon the disability of the Employee (as defined in
Section 6.2); 
 (c) for cause (as defined in Section 6.3), immediately upon notice from the Employer to the Employee, or at
such later time as such notice may specify, unless otherwise provided in Section 6.3; 
 (d) without cause upon not less than
thirty days’ prior notice from the Employer to the Employee; 
 (e) for good reason (as defined in Section 6.4) upon not
less than thirty days’ prior notice from the Employee to the Employer; or 
 (f) by the Company other than for cause upon not
less than thirty days’ prior notice from the Employer to the Employee or by the Employee for good reason, in each case within 12 months following the occurrence of a Change of Control (as defined in Section 6.5(e)). 
 Section 6.2 Definition of Disability. For purposes of Sections 6.1 and 6.3, the Employee will be deemed to have a
“disability” if, as a result of the Employee’s incapacity due to reasonably documented physical illness or injury or mental illness, the Employee shall have been unable for more than six months in any twelve month period to perform
Employee’s duties hereunder on a full time basis and within 30 days after written notice of termination has been give to the Employee, the Employee shall not have returned to the full time performance of such duties. The date of termination in
the case of a termination for “disability” shall be the last day of the aforementioned 30-day period. 
 Section 6.3
Definition of “For Cause.” For purposes of Section 6.1, the phrase “for cause” means: (a) the continued failure, for a period of thirty (30) days after written demand is delivered to the Employee which
specifically identifies the failure, by the Employee substantially to perform the Employee’s duties under this Agreement (other than any such failure resulting from “disability”), (b) the Employee makes, or is found to have made,
a false certification relating to Endo Pharmaceuticals Holdings Inc.’s financial statements, (c) the criminal felony indictment of the Employee by a court of competent jurisdiction, (d) the engagement by the Employee in
serious misconduct that has caused, or in the good faith judgment of the Board of Directors may cause if not discontinued, material harm (financial or otherwise) to the Employer or any of its subsidiaries, if any (provided that with respect to
misconduct that the Board of Directors determines may cause material harm if not discontinued, 

  

 -6- 

 
a written demand is delivered to the Employee specifically identifying the misconduct and the Employee continues the misconduct), such material harm to
include, without limitation, (i) the disclosure of material secret or Confidential Information of the Employer or any of its subsidiaries, if any, (ii) the debarment of the Employer or any of its subsidiaries, if any, by the U.S. Food and
Drug Administration or any successor agency (the “FDA”), or (iii) the registration of the Employer or any of its subsidiaries, if any, with the U.S. Drug Enforcement Administration of any successor agency (the “DEA”) to be
revoked, (e) the debarment of the Employee by the FDA, or (f) the continued material breach by the Employee of this Agreement after written demand is delivered to the Employee which specifically identifies the breach and failure to cure
within thirty (30) days of such demand. 
 Section 6.4 Definition of “For Good Reason.” For purposes of
Section 6.1, the phrase “for good reason” means any of the following: (a) The Employer’s material breach Section 2.4, 3.1 or 3.2 or of this Agreement; or (b) the assignment of the Employee without the
Employee’s consent to a position, responsibilities, or duties of a materially lesser status or degree of responsibility than the Employee’s position, responsibilities, or duties at the Effective Date; or (c) the Employer requiring the
Employee to be based at any office or location more than fifty (50) miles from the Employee’s current principal business location. 
 Section 6.5 Termination Pay. Effective upon the termination of this Agreement, the Employer will be obligated to pay the Employee (or, in the event of Employee’s death, Employee’s designated beneficiary as
defined below) only such compensation as is provided in this Section 6.5. For purposes of this Section 6.5, the Employee’s designated beneficiary will be such individual beneficiary or trust, located at such address, as the Employee
may designate by notice to the Employer from time to time or, if the Employee fails to give notice to the Employer of such a beneficiary, the Employee’s estate. Notwithstanding the preceding sentence, the Employer will have no duty, in any
circumstances, to attempt to open an estate on behalf of the Employee, to determine whether any beneficiary designated by the Employee is alive or to ascertain the address of any such beneficiary, to determine the existence of any trust, to
determine whether any person or entity purporting to act as the Employee’s personal representative (or the trustee of a trust established by the Employee) is duly authorized to act in that capacity, or to locate or attempt to locate any
beneficiary, personal representative, or trustee. 
 (a) Termination by the Employee for Good Reason or by the Employer Without
Cause. If the Employee terminates this Agreement for good reason (except as otherwise provided in Section 6.5(e)) or if the Employer terminates the Employee without cause, the Employer will (i) pay (A) monthly to the Employee
the Employee’s Salary for twenty-four (24) months, and (B) a lump sum equal to two times the Employee’s target Incentive Compensation for the Fiscal Year during which the termination is effective, and (ii) continue to
provide the Employee with the Benefits for twenty-four (24) months. 
 (b) Termination by the Employer for Cause. If the
Employer terminates this Agreement for cause, the Employee will be entitled to receive the Employee’s Salary and Incentive Compensation prorated through the date such termination is effective 
  

 - 7 - 

 (c) Termination upon Disability. If this Agreement is terminated by either party as a
result of the Employee’s disability, as determined under Section 6.2, the Employer will pay the Employee the Salary and Incentive Compensation (if the applicable Performance Targets are met) through the remainder of the calendar month
during which such termination is effective and the period until disability insurance benefits commence (“Disability Coverage Commencement”) under the disability insurance coverage furnished by the Employer to the Employee. From and
after Disability Coverage Commencement and for twenty-four (24) consecutive months thereafter, the Employer will make regular payments to the Employee in the amount by which the Salary exceeds the Employee’s disability insurance benefits.

 (d) Termination upon Death. If this Agreement is terminated because of the Employee’s death, the Employee will be
entitled to receive the Employee’s Salary through the end of the calendar month in which the Employee’s death occurs, and Incentive Compensation (if the applicable Performance Targets are met) for the Fiscal Year during which the
Employee’s death occurs, prorated through the date of the Employee’s death. 
 (e) Termination upon Change of
Control. If (A) following the occurrence of a tender offer, stock purchase, other stock acquisition, merger, consolidation, recapitalization, reverse split, sale or transfer of assets or other transaction, as a result of which any
person, entity or group, other than an Affiliate of the Company prior to the occurrence of such event, as the case may be, (i) becomes the beneficial owner, directly or indirectly, of securities of the Company representing more than 50% of the
ordinary shares of the Company or representing more than 50% of the combined voting power with respect to the election of directors, (ii) appoints a majority of the board of directors of the Company or (iii) obtains the ability to direct
the operations or management of the Company (each of the above, a “Change of Control”) and (B) within twelve (12) months of such Change in Control, the Employee is terminated by the Employer other than for cause, death or
disability or by the Employee for good reason, then the Employee will be entitled to receive (x) any accrued but unpaid Salary to the date on which the termination is effective plus (y) a lump sum payment equal to two times the sum of
(1) the Employee’s then current Salary plus (2) the higher of (a) Employee’s target Incentive Compensation for the Fiscal Year during which the termination is effective or (b) Employee’s Incentive Compensation for
the Fiscal Year immediately preceding the year in which the termination is effective plus (z) Benefits for a period equal to twenty-four (24) months after the date on which the termination is effective. 
 (f) Benefits. Unless otherwise specifically provided herein or otherwise provided for in the Benefits, the Employee’s accrual of, or
participation in plans providing for, the Benefits will cease at the effective date of the termination of this Agreement, and the Employee will be entitled to accrued Benefits pursuant to such plans only as provided in such plans. 
  

 - 8 - 

 ARTICLE 7. NON-DISCLOSURE COVENANT. 
 Section 7.1 Acknowledgments by the Employee. The Employee acknowledges that (a) during the Employment Period and as a part of the
Employee’s employment, the Employee will be afforded access to Confidential Information; and (b) public disclosure of such Confidential Information could have an adverse effect on the Employer and its business. 
 Section 7.2 Agreements of the Employee. In consideration of the compensation and benefits to be paid or provided to the Employee by
the Employer under this Agreement, the Employee covenants as follows: 
 (a) During and following the Employment Period, the Employee
will hold in confidence the Confidential Information and will not disclose it to any person except with the specific prior written consent of the Employer, as otherwise may be required by law or legal process or except as otherwise expressly
permitted by the terms of this Agreement. 
 (b) If any information that the Employer deems to be a trade secret is found by a court
of competent jurisdiction not to be a trade secret for purposes of this Agreement, such information will, nevertheless, be considered Confidential Information for purposes of this Agreement. The Employee hereby waives any requirement that the
Employer submit proof of the economic value of any trade secret or post a bond or other security. 
 (c) None of the foregoing
obligations and restrictions applies to any part of the Confidential Information that the Employee demonstrates was or became generally available to the public other than as a result of a disclosure by the Employee. 
 (d) Upon termination of this Agreement by either party, or upon the request of the Employer during the Employment Period, the Employee will return
to the Employer all Confidential Information in the Employee’s possession or subject to the Employee’s control, and the Employee may not retain any copies, abstracts, sketches, or other physical embodiment of any of the Confidential
Information. 
 ARTICLE 8. NON-COMPETITION AND NON-INTERFERENCE. 
 The Employee covenants that the Employee will not, directly or indirectly during the Employment Period, except in the course of the Employee’s employment hereunder, and during the Post-Employment Period, directly
or indirectly manage, operate, control, or participate in the management, operation, or control of, be employed by, associated with, or in any manner connected with, lend the Employee’s name to, or render services or advice to, any third party
or any business whose products compete (including as described below) in whole or in part with the products of the Employer (disregarding any non-pain management products that were not products promoted by the Employer during the last three years).

  

 - 9 - 

 For purposes of this Article 8, any third party or any business whose products compete includes any
division, group, subgroup, or business unit of any entity with which the Employer has had a product(s) licensing agreement during the Employment Period and any entity with which the Employer is at the time of termination actively negotiating, and
eventually concludes within six (6) months of the Employment Period, a commercial agreement. The term “Post-Employment Period” means the period beginning on the effective date of termination of the Employee’s employment hereunder
and ending on the later to occur of (i) twenty-four (24) months after the effective date of such termination or (ii) the date amounts payable to Employee under Section 6.5 (a), (c) and (e) are to have been paid in full
pursuant to this Agreement (provided that notwithstanding anything in this Agreement to the contrary, such amounts are being timely paid by the Employer). 
 If any covenant in this Article 8 is held to be unreasonable, arbitrary, or against public policy, such covenant will be considered to be divisible with respect to scope, time, and geographic area, and such lesser
scope, time, or geographic area, or all of them, as a court of competent jurisdiction may determine to be reasonable, not arbitrary, and not against public policy, will be effective, binding, and enforceable against the Employee. 
 ARTICLE 9. GENERAL PROVISIONS. 
 Section 9.1
Injunctive Relief and Additional Remedy. The Employee acknowledges that the injury that would be suffered by the Employer as a result of a breach of the provisions of this Agreement (including any provision of Articles 7 and 8) would be
irreparable and that an award of monetary damages to the Employer for such a breach would be an inadequate remedy. Consequently, the Employer will have the right, in addition to any other rights it may have, to obtain injunctive relief to restrain
any breach or threatened breach or otherwise to specifically enforce any provision of this Agreement, and the Employer will not be obligated to post bond or other security in seeking such relief. 
 Section 9.2 Essential and Independent Covenants. The covenants by the Employee in Articles 7 and 8 are essential elements of this
Agreement, and without the Employee’s agreement to comply with such covenants, the Employer would not have entered into this Agreement or employed or continued the employment of the Employee. The Employer and the Employee have independently
consulted their respective counsel and have been advised in all respects concerning the reasonableness and propriety of such covenants, with specific regard to the nature of the business conducted by the Employer. 
 If the Employee’s employment hereunder expires or is terminated, this Agreement will continue in full force and effect as is necessary or
appropriate to enforce the covenants and agreements of the Employee in Articles 7 and 8. 
 Section 9.3 Duty to Mitigate. The
Employee shall not be required to mitigate damages or the amount of any payment required under this Agreement, nor shall the payments due Employee hereunder be reduced or offset by reason of any payments Employee may receive from any other source.

  

 -10- 

 Section 9.4 Representations and Warranties by the Employee. The Employee represents and
warrants to the Employer that the execution and delivery by the Employee of this Agreement do not, and the performance by the Employee of the Employee’s obligations hereunder will not, with or without the giving of notice or the passage of
time, or both: (a) violate any judgment, writ, injunction, or order of any court, arbitrator, or governmental agency applicable to the Employee; or (b) conflict with, result in the breach of any provisions of or the termination of, or
constitute a default under, any agreement to which the Employee is a party or by which the Employee is or may be bound. 
 Section 9.5
Waiver. The rights and remedies of the parties to this Agreement are cumulative and not alternative. Neither the failure nor any delay by any party in exercising any right, power, or privilege under this Agreement will operate as a waiver
of such right, power, or privilege, and no single or partial exercise of any such right, power, or privilege will preclude any other or further exercise of such right, power, or privilege or the exercise of any other right, power, or privilege.

 Section 9.6 Binding Effect; Delegation of Duties Prohibited. This Agreement shall inure to the benefit of, and shall be
binding upon, the parties hereto and their respective successors, assigns, heirs, and legal representatives, including any entity with which the Employer may merge or consolidate or to which all or substantially all of its assets may be transferred.
The duties and covenants of the Employee under this Agreement, being personal, may not be delegated. 
 Section 9.7 Notices.
All notices, consents, waivers, and other communications under this Agreement must be in writing and will be deemed to have been duly given when (a) delivered by hand (with written confirmation of receipt), (b) sent by telecopier (with
written confirmation of receipt), provided that a copy is mailed by registered mail, return receipt requested, or (c) when received by the addressee, if sent by a nationally recognized overnight delivery service (receipt requested), in each
case to the appropriate addresses and telecopier numbers set forth below (or to such other addresses and telecopier numbers as a party may designate by notice to the other parties): 
  

					
	If to the Employer:	 		  	 Endo Pharmaceuticals Holdings Inc.
 100 Endo Boulevard

 Chadds Ford, PA 19317
 Attention: Peter A.
Lankau

			
	If to the Employee:	 		  	 Nancy J. Wysenski
 100 Endo Boulevard
 Chadds Ford, PA 19317

			
		 		  	 and the Employee’s most recent home
 address on file
with the Employer.

  

 -11- 

 Section 9.8 Entire Agreement; Amendments. This Agreement contains the entire agreement
between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral or written, between the parties hereto with respect to the subject matter hereof. This Agreement may not be amended orally,
but only by an agreement in writing signed by the parties hereto. 
 Section 9.9 Governing Law. This Agreement will be governed
by and construed under the laws of the State of Delaware without regard to conflicts of laws principles. The parties hereto agree that, in any legal suit, action or proceeding brought by a party hereto arising out of or based upon this Agreement,
the losing party shall pay to the prevailing party the reasonable attorneys’ fees and expenses incurred by the prevailing party in addition to the award or judgment sum determined due and payable by the losing party, if any, in such action.

 Section 9.10 Section Headings, Construction. The headings of Sections in this Agreement are provided for convenience only
and will not affect its construction or interpretation. All references to “Section” or “Sections” refer to the corresponding Section or Sections of this Agreement unless otherwise specified. All words used in this Agreement will
be construed to be of such gender or number as the circumstances require. Unless otherwise expressly provided, the word “including” does not limit the preceding words or terms. 
 Section 9.11 Severability. If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the
other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 Section 9.12 Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an
original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement. 
 [SIGNATURES
FOLLOW] 
  

 -12- 

 IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written
above. 
  

			
	ENDO PHARMACEUTICALS HOLDINGS INC.
		
	By:	 	 /s/ PETER A. LANKAU

	Name:	 	Peter A. Lankau
	Title:	 	President and Chief Executive Officer
		
		 	 /s/ NANCY J. WYSENSKI

		 	Nancy J. Wysenski

  

 -13-Agreement between AnnTaylor Stores Corporation and Brian Lynch

 Exhibit 10.2 
 Mr. Brian Lynch 
 288 Chestnut Hill Rd 
 Wilton CT,
06897 
 Dear Brian: 
 This will confirm our
agreement with respect to the additional benefits Ann Taylor, Inc. (the “Company”) is granting to you. 
  

	1.	Separation Benefits. You will be entitled to receive the Separation Payments (as defined below) and Benefits Continuation (as described below), if the Company terminates your
employment for any reason other than Cause (as defined in Exhibit A attached hereto). If you are terminated for Cause or you voluntarily terminate your employment, you will not be eligible for any of the Separation Benefits.

  

	 	(a)	Separation Payments – You will be entitled to an amount equal to your annual base salary at the time of your termination plus an amount equal to your targeted bonus under the
Management Performance Compensation Plan, or the annual bonus plan in effect at the time, for the year in which you are terminated. 

  

	 	(i)	Method of Payment – The Separation Payments will be payable in substantially equal installments over the period of 12 months and in the same manner as the Company’s
regular payroll practice. The Separation Payments will be subject to all applicable tax withholding and other applicable deductions. 

  

	 	(b)	Benefit Continuation – If you elect to continue your health benefits in accordance with COBRA, the Company will pay a portion of the COBRA premiums through the period during
which you are receiving Separation Payments. The Company’s contribution will be equal to the amount paid by the Company for the same coverage for active employees. You will be responsible for paying the remaining portion of the COBRA premiums.
After the Separation Payments end or if Benefit Continuation ceases pursuant to Section 2(e) below, you may, if eligible, continue COBRA coverage for the remainder of the COBRA period at your own expense. 

  

	 	(c)	The benefits available pursuant to this Section 1 are contingent upon your execution of a separation agreement that includes, among other provisions, a general waiver and
release of all claims and potential claims against the Company and a non-disparagement provision. The separation agreement must be signed within 22 days of your receipt of the separation agreement or the Company’s obligation to provide you
Separation Benefits hereunder or under the separation agreement shall immediately become null and void. 

	2.	Nonsolicitation; Noncompete. In consideration for the Company agreeing to provide the Separation Benefits to you, you agree that: 

  

	 	(a)	Subject to Section 2(d) below, during the period of your employment and the period you are receiving Separation Payments hereunder and, in the case where your employment is
terminated for Cause or you voluntarily terminate your employment, for a period of twelve months following such termination, you shall not initiate discussions with any person who is then an executive employee of the Company (i.e., director level or
above) with the intent of soliciting or inducing such person to leave his or her employment with a view toward joining you in the pursuit of any business activity (whether or not such activity involves engaging or participating in a Competitive
Business, as defined below). Notwithstanding any other provision of this letter to the contrary, in the event you fail to comply with the preceding sentence, all of your rights hereunder to any future Separation Payments and Benefit Continuation and
all rights with respect to restricted stock and exercisability of stock options shall be forfeited; provided that, the foregoing shall not apply if such failure of compliance commences following an Acceleration Event (as defined in the
Company’s 2003 Equity Incentive Plan). 

  

	 	(b)	Subject to Section 2(d) below, as long as you receive Separation Payments, or in the case where your employment is terminated for Cause or you voluntarily terminate your
employment, for a period of twelve months following such termination, you shall not, without the prior written consent of the Company (which consent shall not be unreasonably withheld), engage or participate in any business which is “in
competition” (as defined below) with the business of the Company or any of its 50% or more owned affiliates (such business being referred to herein as a “Competitive Business”). Notwithstanding any other provision of this Agreement to
the contrary, in the event you fail to comply with the preceding sentence, all of your rights to any future Separation Payments and Benefit Continuation and all rights with respect to restricted stock and exercisability of stock options shall be
forfeited; provided that, the foregoing shall not apply if such failure of compliance commences following an Acceleration Event (as defined in the Company’s 2003 Equity Incentive Plan). 

	 	(c)	In the event of a violation of Sections 2(a) or 2(b) hereof, the remedies of the Company shall be limited to: (i) if such violation occurs during your employment hereunder,
termination for Cause and the associated rights of the Company specified herein resulting from such termination; (ii) regardless of when such violation occurs, forfeiture by you of the payments, benefits and other rights set forth in
Section 1 above if and to the extent provided in such sections; and (iii) the right to seek injunctive relief; provided such injunctive relief may only be sought for competitive activity under Section 2(b) above if such activity
occurs during your employment with the Company or after your dismissal for Cause or you voluntarily terminate your employment. 

  

	 	(d)	For purposes hereof, a business will be “in competition” with the business of the Company or its 50% or more owned affiliates only if (i) the Company’s business
with which the other business competes accounted for 20% or more of the Company’s consolidated revenues as of the end of its most recently completed fiscal year prior to your last day of employment, and (ii) the entity (including all 50%
or more owned affiliates) through which the other business is or will be operated maintains a “women’s apparel” business which generated at least $100 million in revenue during the entity’s most recently completed fiscal year
ended prior to the date you commence (or propose to commence) to engage or participate in the other business. For purposes hereof, “women’s apparel” shall consist of dresses, jackets, pants, shorts, skirts, blouses, sweaters,
T-shirts, outerwear, footwear and accessories. 

  

	 	(e)	 Notwithstanding the foregoing, your engaging in the following activities shall not be construed as engaging or participating in a Competitive Business:
(i) investment banking; (ii) passive ownership of less than 2% of any class of securities of a public company; (iii) engaging or participating in noncompetitive businesses of an entity which also operates a business which is “in
competition” with the business of the Company or its affiliates; (iv) serving as an outside director of an entity which operates a business which is “in competition” with the business of the Company or its affiliates, so long as
such business did not account for 10% or more of the consolidated revenues of such entity as of the end of its most recently completed fiscal year prior to the date you commence (or propose to commence) serving as an outside director;
(v) engaging in a business involving licensing arrangements so long as such business is not an in-house arrangement for any entity “in competition” with the business of the Company or its affiliates; (vi) affiliation with an
advertising agency; and (vii) after cessation of employment, engaging or participating in the “wholesale” side of the women’s apparel business, which for purposes hereof shall mean the design, manufacture and sale of piece goods
and women’s apparel to unrelated third parties, provided that if the entity for 

	 	 
which you so engage or participate (including its affiliates) also conducts a retail women’s apparel business, then effective upon your engaging or
participating in such business, Benefit Continuation shall cease and all Separation Payments shall cease except for amounts representing the excess (if any) of your annual base salary hereunder (at the rate in effect as of your last day of
employment) over your base salary received from such entity and its affiliates, which amounts shall continue to be paid by the Company for the remainder of the period in which you are entitled to receive Separation Payments hereunder. The exceptions
contained in subsection (vii) above and subsection (iii) above to the extent covered by subsection (vii) shall not be applicable if your cessation of employment is voluntary by you and your new engagement or participation involves
“wholesale” operations which include or also conduct retail sales of women’s apparel other than factory outlet or discount stores to liquidate unsold women’s apparel of such wholesale operations. 

  

	3.	Protection of Confidential Information. 

  

	 	(a)	You acknowledge that your employment by the Company involves your obtaining knowledge of confidential information regarding the business and affairs of the Company. In recognition
of the foregoing, you agree that: 

  

	 	(i)	except in compliance with legal process, you will keep secret all confidential matters of the Company which are not otherwise in the public domain and will not intentionally
disclose them to anyone outside of the Company, wherever located (other than to a person to whom disclosure is reasonably necessary or appropriate in connection with the performance of your duties as an executive officer of the Company), either
during or after your employment, except with the prior written consent of the Board of Directors or a person authorized by them; and 

  

	 	(ii)	you will deliver promptly to the Company on termination of your employment or at any other time the Company may so request, all memoranda, notes, records, customer lists, reports
and other documents (whether in paper or electronic form and all copies thereof) relating to the business of the Company which you obtained while employed by, or otherwise serving or acting on behalf of, the Company and which you may then possess or
have under your control. 

  

	 	(b)	If you commit a breach of the provisions of Section 3(a)(i) or 3(a)(ii), the Company shall have the right to have such provisions specifically enforced by any court having
equity jurisdiction. You hereby acknowledge and agree that any such breach or threatened breach will cause irreparable injury to the Company and that money damages will not provide an adequate remedy to the Company. 

 Please understand that this letter is not a contract of continuing employment. Your employment is and
will continue to be “at-will” which means it is for no fixed term and either you or the Company may terminate the employment relationship at any time and for any reason. Please sign below to indicate your agreement to these terms whereupon
this shall become a binding agreement. 
  

					
		 		 	Sincerely,
			
	 	 		 	/s/ Kay Krill
		 		 	Kay Krill
		 		 	President & CEO
		 		 	Ann Taylor Stores Corporation
			
	/s/ Brian Lynch	 		 	Date: September 11, 2007
	Brian Lynch	 		 	

 EXHIBIT A 
 For purposes of this agreement, “Cause” shall be defined as: (1) conviction for the commission of any act or acts constituting a felony under the laws of the United States or any state thereof;
(2) action toward the Company involving dishonesty; (3) refusal to abide by or follow reasonable written directions of the Board, which does not cease within ten business days after such written notice regarding such refusal has been given
to you by the Board; (4) gross nonfeasance which does not cease within ten business days after written notice regarding such nonfeasance has been given to you by the Board; or (5) failure to comply with the provisions of Sections 2 or 3 of
the agreement, or other willful conduct which is intended to have and does have a material adverse impact on the Company

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]